Publication:
Leptin action in normal and pathological pregnancies.

dc.contributor.authorPérez-Pérez, Antonio
dc.contributor.authorToro, Ayelén
dc.contributor.authorVilariño-García, Teresa
dc.contributor.authorMaymó, Julieta
dc.contributor.authorGuadix, Pilar
dc.contributor.authorDueñas, José L
dc.contributor.authorFernández-Sánchez, Manuel
dc.contributor.authorVarone, Cecilia
dc.contributor.authorSánchez-Margalet, Víctor
dc.date.accessioned2023-01-25T10:01:33Z
dc.date.available2023-01-25T10:01:33Z
dc.date.issued2017-11-21
dc.description.abstractLeptin is now considered an important signalling molecule of the reproductive system, as it regulates the production of gonadotrophins, the blastocyst formation and implantation, the normal placentation, as well as the foeto-placental communication. Leptin is a peptide hormone secreted mainly by adipose tissue, and the placenta is the second leptin-producing tissue in humans. Placental leptin is an important cytokine which regulates placental functions in an autocrine or paracrine manner. Leptin seems to play a crucial role during the first stages of pregnancy as it modulates critical processes such as proliferation, protein synthesis, invasion and apoptosis in placental cells. Furthermore, deregulation of leptin levels has been correlated with the pathogenesis of various disorders associated with reproduction and gestation, including polycystic ovary syndrome, recurrent miscarriage, gestational diabetes mellitus, pre-eclampsia and intrauterine growth restriction. Due to the relevant incidence of the mentioned diseases and the importance of leptin, we decided to review the latest information available about leptin action in normal and pathological pregnancies to support the idea of leptin as an important factor and/or predictor of diverse disorders associated with reproduction and pregnancy.
dc.identifier.doi10.1111/jcmm.13369
dc.identifier.essn1582-4934
dc.identifier.pmcPMC5783877
dc.identifier.pmid29160594
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783877/pdf
dc.identifier.unpaywallURLhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jcmm.13369
dc.identifier.urihttp://hdl.handle.net/10668/11827
dc.issue.number2
dc.journal.titleJournal of cellular and molecular medicine
dc.journal.titleabbreviationJ Cell Mol Med
dc.language.isoen
dc.organizationIBIS
dc.page.number716-727
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.pubmedtypeReview
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectgestational diabetes
dc.subjectgrowth restriction
dc.subjectleptin
dc.subjectplacenta
dc.subjectpolycystic ovary syndrome
dc.subjectpre-eclampsia
dc.subjectrecurrent miscarriage
dc.subjectreproduction
dc.subject.meshAdipose Tissue
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshImmunologic Factors
dc.subject.meshLeptin
dc.subject.meshPlacenta
dc.subject.meshPregnancy
dc.subject.meshPregnancy Complications
dc.subject.meshReproduction
dc.titleLeptin action in normal and pathological pregnancies.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number22
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC5783877.pdf
Size:
539.68 KB
Format:
Adobe Portable Document Format